Hepion Pharmaceuticals Announces Board and Compensation Changes
Ticker: CTRVP · Form: 8-K · Filed: Jun 9, 2025 · CIK: 1583771
| Field | Detail |
|---|---|
| Company | Hepion Pharmaceuticals, Inc. (CTRVP) |
| Form Type | 8-K |
| Filed Date | Jun 9, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, executive-compensation, board-of-directors
Related Tickers: HEPA
TL;DR
Hepion Pharma (HEPA) shuffled its board and exec pay. No major surprises.
AI Summary
Hepion Pharmaceuticals, Inc. announced on June 3, 2025, changes in its board of directors and executive compensation arrangements. The filing details the departure of certain officers and directors, the election of new directors, and updates to compensatory arrangements for key personnel. This is a routine corporate governance update.
Why It Matters
Changes in a company's board and executive compensation can signal shifts in strategy or governance, potentially impacting investor confidence and future performance.
Risk Assessment
Risk Level: low — This filing primarily concerns routine corporate governance changes such as director departures and appointments, and executive compensation adjustments, which typically carry low immediate risk.
Key Players & Entities
- Hepion Pharmaceuticals, Inc. (company) — Registrant
- ContraVir Pharmaceuticals, Inc. (company) — Former Company Name
- June 3, 2025 (date) — Date of earliest event reported
- June 9, 2025 (date) — Filing Date
FAQ
What specific roles have been affected by the director and officer changes?
The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers,' but does not specify the exact roles affected in the provided text.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 3, 2025.
What is Hepion Pharmaceuticals, Inc.'s principal executive office address?
Hepion Pharmaceuticals, Inc.'s principal executive office is located at 55 Madison Ave., Suite 400-PMB# 4362, Morristown, NJ 07960.
What was Hepion Pharmaceuticals, Inc. formerly known as?
Hepion Pharmaceuticals, Inc. was formerly known as ContraVir Pharmaceuticals, Inc.
What is the SIC code for Hepion Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for Hepion Pharmaceuticals, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 9, 2025 regarding Hepion Pharmaceuticals, Inc. (CTRVP).